Breaking Finance News

TRADE ALERT- Exact Sciences A Buy Right Now- RW Baird

According to analysts at RW Baird, Exact Sciences’ (NASDAQ: EXAS) recent weakness creates a compelling buying opportunity at current levels.

The firm said that recent new data is showing promising success rates in colorectal screening. They placed an “Outperform” rating on the stock with an $18 price target, suggest upside potential of 37 percent.

The stock reached an intraday high of $14.70 at the beginning of July only to sell off to its current level of $13.13–a decline of about 11 percent. It is slightly above its 50 day moving average of $13.06 and exhibits a descending channel pattern. Volume is diminishing suggesting that selling pressure may be weakening.

[stock-tools exchange="NASDAQ" symbol="EXAS" image_height="230" image_width="350"]

Disclosure: At the time of this writing, the author had no position in the company mentioned.

New to Breaking Finance News? Read about our format here.

 

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.